EBIT: Income before interest and taxes.
Clearmind Medicine Inc. (CMND) had EBIT of $-1.41M for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
-- |
|
$-1.31M |
|
-- |
|
-- |
|
$1.41M |
|
$-1.41M |
|
$0.10M |
|
$-1.31M |
|
$-1.24M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.25M |
|
|
EBIT |
$-1.41M |
$-1.41M |
|
5.34M |
|
5.34M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$3.82M |
|
-- |
|
$0.15M |
|
$3.97M |
|
$2.90M |
|
-- |
|
-- |
|
$2.90M |
|
$1.07M |
|
$0.97M |
|
$1.07M |
|
5.38M |
|
| Cash Flow Statement Financials | |
$-3.45M |
|
$-0.02M |
|
$0.38M |
|
$6.57M |
|
$3.50M |
|
$-3.08M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.32 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-123.26% |
|
-136.05% |
|
-33.09% |
|
-123.26% |
|
$0.20 |
|
$-0.65 |
|
$-0.65 |
|